Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultracet for breakthrough cancer pain
NCT00576173Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Dec 2005
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of tramadol in breakthrough pain, sponsored by Johnson & Johnson. Started Dec 2005; status: completed.
02
Drugs
tramadol
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on NCT00576173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00576173.